Testing Cerebrolysin for prolonged brain injury after bleeding stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation, Mental health clinical trials.
This study tests whether Cerebrolysin can improve recovery in people who remain in a vegetative or minimally conscious state more than 4 weeks after a bleeding stroke. It also tracks safety, to make sure the treatment is not causing harmful side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had a bleeding stroke confirmed by CT or MRI
- It must be more than 4 weeks since the stroke started
- You must currently be in a vegetative state or minimally conscious state
- Age must be 19 to 80
- A caregiver or legal representative must be able to consent in writing
- You must not have major exclusion issues like certain EEG findings or serious organ disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a drug called cerebrolysin can help people who have a bleeding stroke in the outer part of the brain (lobar hemorrhage). It looks at safety and how well it works.
This trial is testing a brain function evaluation system to help understand and possibly improve care for people with disorders of consciousness caused by brain injury, stroke, or lack of oxygen. It is for both acute (recent) and prolonged (lasting) cases.
This study tests whether a medicine called Cerebrolysin can help improve speech in people who have trouble speaking after a stroke. It is for Korean speakers who had their first stroke within the last month.
This trial tests whether adding cerebrolysin (a medication that may help repair brain cells) to the usual treatment improves recovery after a stroke in the basilar artery, which supplies the back of the brain. It is meant for people who have had this type of stroke and are otherwise fairly independent.
This trial tests whether giving a medicine called Cerebrolysin after a delayed procedure to remove a blood clot from the brain can help people recover from a severe stroke. It looks at people who have their clot removed more than 6 hours after symptoms start.
This trial studies treatments to help people regain consciousness after an intracerebral hemorrhage (a bleeding stroke inside the brain). It focuses on adults who are unresponsive to commands within 48 hours, likely from certain bleeding locations, and who meet specific safety and language requirements.
Hear when a new Disorder of Consciousness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.